Xilio Therapeutics Inc (XLO)

1.14 +0.06 (+5.56%) USD  |  NASDAQ  |  May 17, 16:00
1.14 0.00 (0.00%) After-Hours: 20:00
More

Xilio Therapeutics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for XLO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2022. Upgrade now.
Date Value
March 31, 2024 --
March 28, 2024 --
December 31, 2023 --
December 18, 2023 --
May 09, 2023 --
March 02, 2023 --
Date Value
February 24, 2023 --
December 31, 2022 --
September 30, 2022 --
August 09, 2022 --
May 24, 2022 --

Revenue Estimates for Current Quarter Range, Past 5 Years

--
Minimum
May 24 2022
Upgrade
Maximum
Mar 31 2024
Upgrade
Average
--
Median
May 24 2022

Revenue Estimates for Current Quarter Benchmarks

Gilead Sciences Inc Upgrade
FibroGen Inc Upgrade
Avalo Therapeutics Inc Upgrade
IGM Biosciences Inc Upgrade
AEON Biopharma Inc Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade